I Saw Trillions Of Atoms In My Hand Vibrating At A Certain Frequency, Says Zappy Zapolin Describing His First Psychedelics Experience
Portfolio Pulse from Nina Zdinjak
Zappy Zapolin, a prominent figure in the psychedelics space, discusses his transformative experiences with psychedelics and their therapeutic potential. He has advised companies like KetaMD, acquired by Braxia Scientific (OTC:BRAXF), and co-founded Psycheceutical Bioscience (OTC:BWVI). Zapolin advocates for the legal accessibility of psychedelic medicines to treat conditions like PTSD and addiction.
August 13, 2024 | 6:04 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Braxia Scientific, which acquired KetaMD, is highlighted for its involvement in the psychedelics space, particularly in therapeutic applications.
Braxia Scientific's acquisition of KetaMD positions it well in the growing psychedelics market, which is gaining recognition for its therapeutic potential.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Psycheceutical Bioscience, co-founded by Zappy Zapolin, is noted for its advocacy and development in the psychedelics sector.
Psycheceutical Bioscience's involvement in the psychedelics industry, driven by a prominent figure like Zapolin, suggests potential growth and increased investor interest.
CONFIDENCE 85
IMPORTANCE 65
RELEVANCE 70